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Objective: to determine if thyroid dysfunction can induce periodontal 
disease, by comparing salivary and serum levels of IL-6 and TNF-α in 
patients with thyroid dysfunction without clinical periodontal changes to 
healthy controls. 
Material and Methods: 28 randomly selected adult patients with thyroid 
dysfunction and 24 healthy adults were enrolled. Venous blood and un-
stimulated saliva were assessed for TNF-α and Interleukin-6 levels, using 
ELISA-sandwich methods. Comparisons between groups were made using 
Mann-Whitney and Kruskal-Wallis tests, and the level of significance was 
set at p≤0.05. 
Results: Mean values of serum TNF-α concentration for patients with 
hypothyroidism (132.29±91.26pg/ml) were 4 times higher than in subjects 
with hyperthyroidism (32.24±29.46pg/ml) and almost 15 times higher than 
in controls, but there was no significant difference between hypo- and 
hyperthyroid subjects. Mean values of salivary TNF-α were significantly 
higher in hyperthyroid subjects than in controls (p=0.011), also in 
hypothyroid subjects than in controls (p=0.009), but there was no significant 
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difference between hypo- and hyperthyroid subjects. Serum IL-6 had 
apparently much higher levels in study groups (99.39±54.41pg/ml 
hyperthyroid and 68.69±45.94pg/ml in hypothyroid) compared with controls 
(11.23±2.14pg/ml), but the differences were not statistically significant. 
Mean values of salivary IL-6 were significantly higher both in hyperthyroid 
and hypothyroid subjects than in controls (p<0.001), and there was an 
extremely significant difference between hypo- and hyperthyroid subjects 
(p<0.001). 
Conclusion: Serum and salivary levels of TNF-α and IL-6 represent a well 
individualized biologic indicator for appreciating the development of 
periodontitis in subjects with thyroid dysfunction. Hyperthyroidism can 
induced more important periodontal destructions than hypothyroidism.  
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Introduction 
Triiodothyronine (T3) and thyroxine (T4) were demonstrated to have 
a fundamental role in normal growth, development, skeletal maturation and 
bone turnover (Ganong 2001, Bland 2000). Variations in blood levels of T3 
and T4 are strongly associated with hypo- and hyperthyroidism, with clinical 
consequences upon bone growth and development (Little 2006). Thus, in 
hypothyroidism the bone turnover is slow, bone growth and maturation are 
retarded and these patients will exhibit in time osteosclerosis and high risk of 
bone fracture (Allain et al 1995, Vestergaard 2002). In hyperthyroidism there 
is accelerated bone maturation with reduced bone mineral density, high bone 
turnover and a negative calcium balance (Allain et al 1995, Vestergaard 
2002, Suwanwalaikorn et al 1996, Siddiqi et al 1998). Alveolar bone 
resorption is the most important clinical parameter used to assess the severity 
of periodontal disease; therefore, variations of T3 and T4 blood levels may 
be considered a modulating factor in chronic marginal periodontitis. 
Several studies showed that thyroid hormones play an important role 
in bone resorption by influencing osteoprotegerin (OPG) and receptor 
activator of nuclear factor kappa-B ligand (RANKL) mechanism (Akalin et 
al 2002). This is accompanied by local production of IL-6 and other bone 
regulating factors (Siddiqi et al 1998, Siddiqi et al, 1999, Tokuda et al, 
1998). Thyroid dysfunction has a negative effect on IL-6 and TNF-alpha, 
which play an important role in osteoclast differentiation and function, 
without any influence from RANKL-RANK interactions (Kanatani et al 
2004). 
The aim of this research was to compare the salivary and serum levels 
of IL-6 and TNF-α in patient with thyroid dysfunction without periodontal 
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changes to healthy controls and to identify whether these cytokines might be 
indicators for the development of periodontal disease.  
 
Material and methods  
Subjects: 
28 randomly selected patients (19 female and 9 male, age range: 23-
53 years) with thyroid dysfunction were enrolled in the study. Thyroid 
dysfunction was diagnosed by the endocrinologist based on clinical signs and 
lab examinations, such as TSH, T3 and fT4 serum levels, and all subjects 
were under specific treatment for their thyroid dysfunction at the time of 
enrollment.  
 These subjects were divided according to their thyroid dysfunction 
into 2 groups: hyperthyroidism (n=15, 10 female and 5 male), and 
hypothyroidism (n=13, 9 female and 4 male). 
 24 volunteers (19 women and 5 men) of good general health 
condition and no thyroid dysfunction, no ongoing disease and no medication, 
served as controls. 
 Inclusion criteria were: more than 18 years of age, presence of at least 
20 sites per jaw, no periodontal problems or periodontal treatment within the 
last six months and no medication intake that might have an influence on 
periodontal status or might have been prescribed for long-term treatment of 
metabolic diseases such as rheumatoid arthritis or osteoporosis. 
 Smokers, subjects over 60 years of age, or patients presenting any 
kind of inflammatory disease within the last 3 months were excluded from 
the study.  
 The study protocol had been approved by the local Ethical 
Committee (Number 16/18.07.2011) of the University of Medicine and 
Pharmacy from Tirgu-Mures. All patients were asked to sign an informed 
consent. 
 
Method of analysis: 
 After obtaining informed consent, 2 ml of un-stimulated saliva were 
collected into a sterile tube from each enrolled subject, centrifuged for 3 min 
at 3.000 rpm and clarified supernatant was filtered through a low protein 
binding membrane, separated in polyethylene recipients, then marked for 
identification and stored in the refrigerator until examination. 
 Venous blood samples were obtained by venipuncture using an 
adequate closed system sample. Tubes were then centrifuged at 3,000 rpm/10 
min and stored at -20oC until analyzed. 
 Salivary and serum TNF-α levels were assessed with the ELISA-
sandwich method using a commercially available immunoassay kit (OptEIA 
human TNF-α, Pharmingen, USA) according to the manufacturer’s 
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guidelines. The values of salivary and serum TNF-α levels were extrapolated 
from a curve drawn using TNF-α standard and reported in pg/ml. 
 Saliva and serum interleukin-6 levels were evaluated using a 
commercially available enzyme-linked immunoabsorbent, sandwich ELISA 
assay (DuoSet ELISA Development System, R&D Systems, USA) according 
to the manufacturer’s guidelines. Results were reported as total amount of 
IL-6 (in pg/ml). 
 
Statistical Analysis: 
 Statistical analysis was performed using Microsoft Excel 2003 and 
Statistica 5.0. Data are expressed as mean and standard deviation (SD). 
Kolmogorov-Smirnov and Lilliefors tests were used to analyze statistic 
distribution of parameters. Parametric and nonparametric tests were used to 
compare variables. Comparisons between groups were made for non-
normally distributed variables using Mann-Whitney U and Kruskal-Wallis 
tests. The level of significance was set at p ≤ 0.05. 
Results. The mean age for the subjects with hyperthyroidism was 
43.2±2.94 years and 46.15±2.36 years for patients with hypothyroidism. The 
healthy controls were aged 42.12±3.34. The groups did not differ 
significantly from each other with regards to the mean age of the subjects. 
General clinical parameters (mean ± SD) of the 2 groups with thyroid 
dysfunction are provided in Table 1. The Body Mass Index (BMI) of the 
patients with hypothyroidism was significantly increased compared to 
patients with hyperthyroidism and controls. The serum glucose level did not 
vary among groups, whereas TSH levels displayed a statistically significant 
increase in patients with decreased thyroid function and FT4 displayed a 
statistically significant increase in patients with hyperthyroid function, 
respectively. Healthy controls had all the clinical parameters at normal 
values. All subjects in the study groups presented healthy periodontal tissues.  
Table 1. Clinical parameters in patients with thyroid dysfunction 
Hyperthyroidism Nr. of cases Mean value Minimum Maximum Standard deviation 
BMI 15 21.23 12.89 32.38 2.30 
Glycemia (mg/dL) 15 90.88 71 106 4.60 
TSH (uUI/mL) 15 0.069 0.005 0.23 0.09 
FT4 (ng/dL) 15 2.86 0.47 13.62 0.82 
      
Hypothyroidism      
BMI 13 28.29 22.83 33 2.09 
Glycemia (mg/dL) 13 95.63 65 118 4.37 
TSH (uUI/mL) 13 17.64 1.52 77.44 7.78 
FT4 (ng/dL) 13 0.95 0.16 1.58 0.14 
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In 50 out of 52 subjects, serum TNF-α was detected. Serum TNF-α 
concentrations were 32.24±29.46 pg/ml in subjects with hyperthyroidism and 
132.29±91.26 pg/ml in subjects with hypothyroid function, respectively. 
Mean values of serum TNF-α of patients with hypothyroid function showed 
an approximately 4 times higher level than in hyperthyroid subjects and 
almost 15 times higher level than in controls. However, there was no 
significant difference between hypo- and hyperthyroid subjects (Table 2). 
Serum TNF-α showed a positive correlation with age in hyperthyroid 
subjects with tendency to statistic signification (r=0.44, p=0.11). 
Table 2. Variation of serum TNF-α in study groups and comparisons with controls 
Groups Serum TNF-α (pg-mL) mean. ± std. err. 
Hyperthyroidism (n=14) 32.24 ± 29.46* 
Hypothyroidism (n=12) 132.29 ± 91.26† 
Controls (n=24) 8.69 ± 1.76 
p=0.05, Kruskal-Wallis ANOVA test 
*p˃0.05, †p<0.05,‡p<0.01, §<0.001 
All groups were compared with the control group 
 
Increased levels of serum TNF-α in hypothyroid subjects can have 
two explanations: BMI in subjects with hypothyroid function was increased 
(mean value ± std. err. 28.29±2.09), showing first degree obesity; on the 
other hand, three patients with hypothyroidism had anti-TPO auto antibodies 
(autoimmune thyroiditis), that can be the reason for the increased cytokine 
levels. Two of these subjects had TNF-α value of 966 pg/mL, respectively 
613 pg/mL. 
Salivary TNF-α was detected in 50 of 52 samples. Hyperthyroid 
subjects expressed a higher level of TNF- α in the saliva than hypothyroid, 
and both groups had higher salivary TNF-α levels than controls (p<0.05) 
(Table 3).  
Table 3. Measured salivary TNF- α and comparisons with controls 
Groups Salivary TNF-α (pg-mL) mean. ± std. err. 
Hyperthyroidism (n=14) 11.52 ± 3.08† 
Hypothyroidism (n=12) 10.53 ± 3.24‡ 
Controls (n=24) 8.86 ± 4.68 
p=0.05, Kruskal-Wallis ANOVA test 
*p˃0.05, †p<0.05,‡p<0.01, §<0.001 
All groups were compared with the control group 
 
There was no correlation of salivary TNF-α with any other clinical 
parameter, irrespective of the thyroid dysfunction, but we found a significant 
positive correlation between salivary TNF-α and salivary IL-6 in the total 
study group (r=0.410, p=0.006). 
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Serum IL-6 had apparently much higher levels in study groups 
(99.39±54.41 pg/ml hyperthyroidism and 68.69±45.94 pg/ml in 
hypothyroidism) compared to controls (11.23±2.14 pg/ml), but the 
differences were not statistically significant (Table 4). 
Table 4. Serum IL-6 variation in study groups and comparisons with controls 
Groups Serum IL-6 (pg-mL) mean. ± std. err. 
Hyperthyroidism (n=15) 99.39 ± 54.41* 
Hypothyroidism (n=13) 68.69 ± 45.94* 
Controls (n=24) 11.23 ± 2.14 
p=0.05, Kruskal-Wallis ANOVA test 
*p˃0.05, †p<0.05,‡p<0.01, §<0.001 
All groups were compared with the control group 
 
Salivary IL-6 levels were significantly higher in hyperthyroid 
subjects than in hypothyroid ones, and both thyroid dysfunction groups had 
significant higher levels than healthy controls (p<0.001) (Table 5). 
Table 5. Measured salivary IL-6 and comparisons with controls 
Groups Salivary IL-6 (pg/mL)mean. ±  std. err. 
Hyperthyroidism (n=15) 21.07 ± 6.71§ 
Hypothyroidism (n=13) 16.63 ±2.36§ 
Controls (n=24) 7.64 ± 2.98 
p=0.05, Kruskal-Wallis ANOVA test 
*p˃0.05, †p<0.05,‡p<0.01, §<0.001 
All groups were compared with the control group 
 
Discussions. Interleukin-6 (IL-6) and tumor necrosis factor α (TNF-
α) are two major pro-inflammatory cytokines that are locally produced in 
different tissues in different pathological situations, including thyroid 
dysfunction (Bartalena et al 1994, Sekeroglu et al2006). These locally 
produced factors enter systemic circulation and spread in whole body, 
including into periodontal tissues. It is thought that cytokines stimulate 
resident cells of the periodontium to produce metalloproteinases, molecules 
that mediate connective tissue destruction and induce the differentiation and 
activation of osteoclasts, leading to alveolar bone destruction (McGee et al, 
1998). 
In our study, the cytokines that were produced due to thyroid 
dysfunction might have been the initiators of an amplified inflammatory 
cascade. In combination with endotoxins produced by germs in dental plaque 
this might lead to higher local inflammatory mediator concentrations, 
including cytokines and prostaglandins, higher concentrations of matrix 
metalloproteinase (MMP) and of other proteinases with destructive effects 
on bone and conjunctive tissue, in the end leading to osteoporosis and 
periodontal breakdown. 
European Scientific Journal   May 2014  edition vol.10, No.15   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
80 
Recently, several studies were published regarding the correlation 
between thyroid dysfunction and inflammatory markers. Sekeroglu et al. 
(2006) suggested that in the absence of non-thyroidal dysfunction, IL-6 
might be considered a useful marker for thyroid destructive processes, with a 
direct augmentative effect on cytokine serum concentrations. Furthermore, it 
was suggested that IL-6 production from mononuclear cells in hyperthyroid 
women was higher than in controls (Lakatos et al 1997).  There are several 
mechanisms which can lead to increased levels of serum IL-6, a common 
feature of hyperthyroidism. Among these are: bone resorption, autoimmune 
inflammatory conditions or excessive concentrations of T3 and T4, all 
induced by thyrotoxicosis (Fenkci et al 2001). Regardless of the mechanisms 
involved, in hyperthyroidism there will always be an increased level of IL-6, 
which in turn will have a stimulatory effect on osteoclasts differentiation and 
proliferation, with bone resorption as final effect.  
In bone turnover there are two important metabolic mechanisms: new 
bone formation by osteoblasts and old bone degradation by osteoclasts. Total 
bone mass is influenced by the balance between bone formation and 
resorption. Assessment of bone formation markers (osteocalcin and alkaline 
phosphatase) in hyper- and hypothyroid patients pointed to the fact that bone 
turnover was much higher in hyperthyroid subjects. But by determining the 
serum IL-6, IL-8 and TNF-α levels there was no correlation found between 
cytokines and bone turnover markers (Sekeroglu et al 2006). Celik et al. 
(1995), however, suggested that resorptive effect on the bone in 
hyperthyroidism is supposed to be cytokine mediated. Chopra et al. (1991) 
reported no significant difference between serum TNF-α level in hypothyroid 
and hyperthyroid subjects vs. controls, whereas Siddiqi et al. (1999) reported 
higher serum TNF-α levels in hyperthyroid patients. This is in contrast to our 
findings. In the present study, hypothyroid patients had an increased Body 
Mass Index (BMI) pointing to an obesity tendency and causing higher serum 
levels of these cytokines (Vikram 2011). Additionally, three of the 
hypothyroid patients had anti-TPO antibodies (autoimmune thyroiditis). 
These findings might explain the high serum TNF-α level in patients with a 
decreased thyroid function. 
On the other hand, several clinical studies demonstrated that 
periodontal disease itself determines higher serum and salivary pro-
inflammatory cytokines levels, especially TNF-α, IL-10 and IL-6 (Ng et al 
2007, de Queiroz et al 2008, Frodge et al 2008, Lia Coman 2009). Our 
results showed higher levels than those of de Queiroz and coworkers (2008). 
These authors reported serum TNF-α levels of 6.4±17.3 pg/ml in 17 subjects 
with chronic periodontitis compared with serum TNF-α levels of 0.9±1.8 
pg/ml in 8 healthy controls. In 2009, Coman (Lia Coman 2009) described 
serum TNF-α levels of 9.8±2.35 pg/ml in subjects with periodontal disease. 
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The significant differences might be due to systemic condition, confirming 
the hypothesis that systemic disease exacerbates periodontal disease. 
Likewise, the salivary cytokine levels determined were higher than 
those described by different authors who investigated subjects with 
periodontal disease but systemically healthy. In our study we measured 
salivary TNF-α levels of 11.52±3.08 pg/ml and salivary IL-6 of 21.07±6.71 
pg/ml in subjects with hyperthyroidism, respectively salivary TNF-α levels 
of 10.53±3.25 pg/ml and salivary IL-6 of 16.63±2.36 pg/ml in subjects with 
hypothyroidism. Ng et al. (2007) reported salivary TNF-α levels of 1.9±0.2 
pg/ml and salivary IL-6 of 15.1±47.8pg/ml in 98 subjects with periodontal 
disease. In 2008, in 35 subjects with moderate and severe periodontitis 
salivary TNF-α levels of 4.33 pg/ml were reported (Frodge et al 2008), and 
in 2009 salivary TNF-α levels of 7.31±0.91 pg/ml were described in 
periodontal disease subjects (Lia Coman 2009). The significant differences 
salivary TNF-α levels are due to systemic disease, such as thyroid 
dysfunction. 
Our results point to the fact that thyroid hormones, in lower or higher 
concentrations than normal, might co-induce periodontal disease, by raising 
serum and salivary cytokine levels, which activate different pathways 
determining alveolar bone and conjunctive tissue destruction. 
Despite of very significantly increased concentrations of cytokines, 
no correlations between cytokine levels and periodontal status was found, 
since the subjects included in this study had no clinical modifications of 
periodontal tissues yet. Similar results were reported by Scapoli et al. (2007) 
and Teles et al. (2009).  
 
Conclusion 
In conclusion, the present results suggest that serum and salivary 
levels of pro-inflammatory cytokines TNF-α and IL-6 represent a well 
individualized biologic indicator for assessing the possible development of 
periodontal disease in subjects with thyroid dysfunction. Hyperthyroidism 
can induce more important periodontal destructions than hypothyroidism, 
with both thyroid dysfunctions having an effect on periodontal tissues 
through inflammatory mediators such as cytokines. Determining TNF-α and 
IL-6 levels in total saliva is a comfortable, simple and relatively safe method 
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